Introduction
============

Recently, artificial intelligence (AI) has made remarkable progress in medicine. Humanity will undergo a dramatic and irreversible change when AI becomes very advanced, which will likely occur in this century ([@b1-ol-0-0-11214]). AI has exceeded human experts in the field of games with perfect results ([@b2-ol-0-0-11214]), revealing novel strategies or findings. Therefore, as AI may be able to recognize certain information that conventional procedures cannot, it may also provide more precise diagnosis in practical medicine. Additionally, AI may be able to assist clinicians in practical medicine, reducing time and effort. For example, it has been reported that using AI-assisted colposcopy may reduce the time and effort it takes for a gynecologist to become a colposcopy expert, resulting in more time to improve other skills, training and activities ([@b3-ol-0-0-11214]). Moreover, the use of AI for predicting live births from blastocysts, to a level similar to that of specialists, may result in time saved for embryologists, reducing the financial costs of training ([@b4-ol-0-0-11214]). The aim of the present study was to investigate the feasibility of applying deep learning, a type of AI using both image and non-image information simultaneously, for gynecological clinical practice.

Uterine cervical cancer is a major public health problem as it is the third most common cancer in women and the leading cause of cancer-associated mortality among women in Central America, South-Central Asia, Middle and Western Africa and Melanesia ([@b5-ol-0-0-11214]). New methodologies to prevent cervical cancer should be made available and accessible to women in all countries ([@b5-ol-0-0-11214]).

Colposcopy is a well-established procedure for examining the uterine cervix under magnification ([@b6-ol-0-0-11214]--[@b8-ol-0-0-11214]). When lesions are treated with 3--5% acetic acid, colposcopy can detect and recognize cervical intraepithelial neoplasia (CIN) ([@b6-ol-0-0-11214]). Classification systems, such as the Bethesda system established in 2002, are used to categorize lesions as low-grade squamous intraepithelial lesions (LSILs) or high-grade SILs (HSILs) ([@b9-ol-0-0-11214],[@b10-ol-0-0-11214]), previously referred to as CIN1 and CIN2/CIN3, respectively ([@b9-ol-0-0-11214]). In clinical practice, distinguishing HSIL from LSIL in biopsy specimens is important as further examination or treatment, such as conization, may be required for HSIL.

In 2003, Burd ([@b11-ol-0-0-11214]) revealed that the Human papilloma virus (HPV) is essential to the transformation of the cervical epithelium. Based on genomic differences, DNA sequencing has identified \>200 types of HPV, which can be grouped into low-risk (including types 6, 11, 42, 43 and 44) and high-risk (including types 16, 18, 31, 33, 34, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and 70) HPV. In the high-risk group, certain HPV types are less frequently identified in cancers but are often present in SIL cells. The risk of progression for HPV types 16 and 18 is greater by \~40% compared with that for other HPV types ([@b11-ol-0-0-11214]). Thus, HPV types may be associated with SILs because high-risk HPV may be more detectable in HSILs compared with LSILs. Information on HPV types may be beneficial to SIL diagnosis. However, the possibility of combining colposcopy findings with HPV types has not been previously explored.

Deep learning with a convolutional neural network ([@b12-ol-0-0-11214],[@b13-ol-0-0-11214]) to the realm of AI was applied to develop an original classifier for predicting HSIL or LSIL from colposcopy images ([@b3-ol-0-0-11214]) and HPV types. The aim of the present study was to determine whether AI could accurately evaluate colposcopy findings (combined with HPV types), compared with conventional colposcopy findings by gynecologic oncologists, and also to investigate the feasibility of applying deep learning (a class of AI using both image and non-image information simultaneously) in clinical gynecological clinical practice.

Materials and methods
=====================

### Patients

The present study used fully de-identified patient data and was approved by the Institutional Review Board of Shikoku Cancer Center (approval no. 2017-81). The study was explained to patients who were not limited by age, had no prior treatment of the uterine cervix and had advanced lesions of the cervix biopsied at Shikoku Cancer Center between January 2012 and December 2017. Patients were directed to a website with additional information, including an opt-out option for the study. As the present study was a fully de-identified retrospective study, the Institutional Review Board of Shikoku Cancer Center approved the informed consent by the explanation including the opt-out option for patients to choose to withdraw from this study as informed consent. HPV tests had been performed in routine examination for patients with abnormal cervical cytology reports or abnormal colposcopy findings indicating neoplastic disease diagnosed by gynecological oncologists at Shikoku Cancer Center. HPV tests were not performed specifically for this study. Gynecological oncologists determined the necessity for biopsy in routine conventional practice for patients with abnormal cervical cytology reports of ASC-US, LSIL, HSIL, atypical squamous cells cannot ruled out HSIL (ASC-H), squamous cell carcinoma (SCC), adenocarcinoma *in situ* (AIS), atypical glandular cells (AGC) and adenocarcinoma (Adenoca), as well as for patients with abnormal cervical cytology reports or abnormal colposcopy findings indicating neoplastic disease such as LSIL/CIN1, HSIL/CIN2 and HSIL/CIN3. HPV types were tested by either one of the following commercially available PCR-based assay kits: Cobas^®^ 4800 system HPV (Roche Diagnostics), which detects high-risk HPV genotypes such as 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68; or Amplicor^®^ HPV (Roche Diagnostics), which detects high-risk HPV genotypes such as 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68. The design of the study was based on the routine practice at Shikoku Cancer Center. A total of 253 patients who underwent cervical punch biopsy combined with HPV typing test and had an image of colposcopy captured were enrolled in this study.

### Images

Colposcopy images of lesions processed with 3% acetic acid prior to biopsy were captured, cropped and saved in JPEG format. The image data were input retrospectively for deep learning.

### AI preparation

All de-identified images saved offline were transferred to the AI system. For the test dataset, 20% of the images were randomly selected; the remaining images were used as the training dataset. Next, 80% of the training dataset images were used to train the AI classifier, and the remaining images were used as the validation dataset. Thus, these datasets did not overlap. The AI classifier was trained using a training dataset and simultaneously validated and tested using the test dataset. The training datasets were augmented, because colposcopy image processing of arbitrary degrees of rotation can yield images resulting in different vector data for the same category.

### AI classifier

Classifier programs were developed using supervised deep learning with a convolutional neural network architecture ([@b12-ol-0-0-11214],[@b14-ol-0-0-11214]) catenated with a HPV type tensor. A number of convolutional neural networks were tested by varying image size (50×50, 75×75 and 100×100 pixels), L2 regularization ([@b15-ol-0-0-11214],[@b16-ol-0-0-11214]) and architectures consisting of a combination of convolution layers with kernels ([@b17-ol-0-0-11214]--[@b19-ol-0-0-11214]), pooling layers ([@b20-ol-0-0-11214]--[@b23-ol-0-0-11214]), flattened layers ([@b24-ol-0-0-11214]), linear layers ([@b25-ol-0-0-11214],[@b26-ol-0-0-11214]), rectified linear unit layers ([@b27-ol-0-0-11214],[@b28-ol-0-0-11214]), catenated layers, batch normalization layers ([@b29-ol-0-0-11214]) and a softmax layer ([@b30-ol-0-0-11214],[@b31-ol-0-0-11214]) which demonstrated the probability of LSIL or HSIL from an image ([Table I](#tI-ol-0-0-11214){ref-type="table"}).

Cross-validation ([@b32-ol-0-0-11214]--[@b34-ol-0-0-11214]), which is a method for model selection, was applied to identify the optimal machine learning method. The suitable number of images for the training data was determined using the 5-fold cross-validation method, which reveals the optimal number of training data and can be used to avoid overfitting, a modeling error that occurs when a classifier is too closely fit to a limited set of data points ([@b35-ol-0-0-11214]--[@b40-ol-0-0-11214]). After the optimal number of training data was calculated, the classifier that exhibited the highest accuracy was selected. Conventional colposcopy diagnosis and AI colposcopy diagnosis-catenated HPV types in the test dataset were compared. A flow chart of the development of the AI classifier is presented in [Fig. 1](#f1-ol-0-0-11214){ref-type="fig"}.

### Development environment

The following development environment was used: A Macintosh running OS X 10.14.5 (Apple, Inc.) and Mathematica 12.0.0.0 (Wolfram Research, Inc.).

### Statistical analysis

The laboratory and AI classifier data were compared using Mathematica 12.0.0.0 (Wolfram Research, Inc.). The Cochran Armitage test, Cohen\'s κ, χ^2^ test and Fisher\'s exact test were used. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

The number of patients with cytology reports were stratified as follows: HSIL, 149; LSIL, 75; AUC-US, 43; ASC-H, 38; SCC, 18; AGC, 2; AIS; 2; Adenoca, 2; NILM, 8. Mean ± standard deviation, median and range of patient age in the HSIL vs. LSIL groups were 31.66±5.01 vs. 33.75±8.94, 32 vs. 33 and 19--46 vs. 19--62, respectively. The pathological diagnoses and the corresponding number of patients who underwent punch biopsy were as follows: HSIL, 213; LSIL, 97; squamous cell carcinoma, 12; adenocarcinoma, 5; adenocarcinoma *in situ*, 2; and microinvasive squamous cell carcinoma, 1 ([Table II](#tII-ol-0-0-11214){ref-type="table"}). The HPV types of the patients were as follows: Type 16, 87; type 18, 8; type 16 and 18, 4; high-risk HPV but not type 16 or 18, 159; and HPV negative, 13. A total of 57 patients (17.2%) did not receive a HPV type test. Conventional colposcopy diagnoses based on pathological results and HPV types are presented in [Tables III](#tIII-ol-0-0-11214){ref-type="table"} and [IV](#tIV-ol-0-0-11214){ref-type="table"}. A total of 20/273 patients had no image data.

A total of 253 patients with colposcopy images, pathological LSIL or HSIL and known HPV types were finally enrolled in this study. The ages of patients with pathological HSIL and LSIL were 31.66±4.83 and 30.12±5.10 (mean ± standard deviation), respectively (data not shown). The median age (range) of pathological HSIL and LSIL were 32 ([@b19-ol-0-0-11214]--[@b46-ol-0-0-11214]) and 33 ([@b19-ol-0-0-11214]--[@b62-ol-0-0-11214]), respectively (data not shown). HPV types were reclassified as follows: Type 16 or 18 were considered high-risk HPV, and not type 16 or 18 was considered to represent low-risk HPV/HPV-negative due to the limited number of available HPV types and pathological results. HPV-negative described the absence of high-risk HPV, not type 16 or 18.

The numbers of patients with type 16 and/or 18, high-risk HPV but not type 16 or 18 and HPV-negative were 85, 156 and 12, respectively ([Table II](#tII-ol-0-0-11214){ref-type="table"}). The numbers of patients with HSIL and LSIL were 210 and 43, respectively. Among the 210 pathological HSIL cases, the numbers of type 16 and/or 18, high-risk HPV but not type 16 or 18 and HPV-negative were 81, 123 and 6, respectively. Among the 43 pathological LSIL cases, the numbers of type 16 and/or 18, high-risk HPV but not type 16 or 18 and HPV-negative were 4, 33 and 6, respectively. The HPV types were associated with the pathological results (P\<6.70×10^−6^; Cochran Armitage test). HPV-negative results were observed in 2.85% (6/210) and 14.00% (6/43) of HSIL and LSIL, respectively. In the present study, type 16- or 18-positive HPV in pathological HSIL and LSIL were observed in 38.6 and 9.3% of cases, respectively. The incidence of type 16 and/or 18 positivity in pathological HSIL was significantly higher, compared with that in LSIL (P\<0.0005; Fisher\'s exact test with Yates\'s correction).

Among the 210 pathological HSIL cases, 177 patients received a conventional colposcopy diagnosis by gynecologists of CIN2 (HSIL) or CIN3 (HSIL), 29 were diagnosed with CIN1 (LSIL), three were diagnosed with invasive cancer and one was diagnosed with cervicitis. Among the 43 pathological LSIL cases, 13 received a conventional colposcopy diagnosis by gynecologists of HSIL, 25 were diagnosed with LSIL and 5 with cervicitis. The accurate diagnoses of HSIL and LSIL were 202 out of 253 (0.798). The accuracy, sensitivity, specificity, positive predictive value, negative predictive value and Youden\'s J index of the conventional colposcopy diagnosis for pathological HSIL were 0.828 (202/244), 0.859 (177/206), 0.658 (25/38), 0.932 (177/190), 0.463 (25/54) and 0.517, respectively.

Among the 85 cases with HPV type 16 and/or 18, 71 received a conventional colposcopy diagnosis by gynecologists of CIN2 (HSIL) or CIN3 (HSIL), 10 were diagnosed with CIN1 (LSIL), two with cervicitis and two with invasive cancer. Among the 156 cases with HPV type 16 and/or 18, 113, 40, 2 and 1 received a conventional colposcopy diagnosis by gynecologists of CIN2 (HSIL) or CIN3 (HSIL), CIN1 (LSIL), cervicitis and invasive cancer, respectively. Among the 12 HPV-negative cases 6, 4 and 2 received a conventional colposcopy diagnosis by gynecologists of CIN2 (HSIL) or CIN3 (HSIL), CIN1 (LSIL) and cervicitis, respectively. There are no relationships between HPV types and colposcopy.

The highest accuracy for HSIL of the best AI classifier combined with HPV types for a test dataset was 0.941 (48/51) when the number of the augmented training dataset was 1,212, the value of L2 regularization was 0.02, and the image size was 50×50 pixels. The accuracy, sensitivity, specificity, positive predictive value, negative predictive value, Youden\'s J index ([@b41-ol-0-0-11214]), the area under the receiver operating characteristic curve (AUC) ± standard error, the 95% confidence interval of the AUC and Cohen\'s k ([@b42-ol-0-0-11214]) coefficients of HSIL for the AI colposcopy combined with HPV types and pathological results are presented in [Table V](#tV-ol-0-0-11214){ref-type="table"}.

The comparison of the conventional colposcopy diagnosis by gynecological oncologists and the best AI classifier for the test dataset is presented in [Table VI](#tVI-ol-0-0-11214){ref-type="table"}. As the AI classifier was not trained for cervicitis or invasive cancer, when the colposcopy diagnosis was limited to HSIL and LSIL by ignoring colposcopy diagnoses of cervicitis and invasive cancer, the Cohen\'s k coefficient of the colposcopy diagnosis and the AI classifier was 0.407. The agreement of the two methods was moderate ([@b43-ol-0-0-11214]), but not significant (P=0.077).

The comparison of the conventional colposcopy diagnosis by gynecological oncologists and the pathological results for the test dataset is presented in [Table VI](#tVI-ol-0-0-11214){ref-type="table"}. The accurate number of HSIL and LSIL by conventional colposcopy for the test dataset was 43 of 51 (0.843). The conventional colposcopy results for the test dataset and for all of the datasets were not significantly different, and the time required for classification was \<0.2 sec per patient.

Discussion
==========

In the present study, a classifier was developed using deep learning with convolutional neural networks using images of cervical SILs combined with HPV types to predict the pathological diagnosis. The accuracy for the test dataset achieved by the classifier and by gynecological oncologists was 0.941 and 0.843, respectively; the latter accuracy was calculated tentatively, and these two accuracies could not be compared as the AI was trained for HSIL and LSIL classes, whereas colposcopy could identify lesions such as cervicitis, invasive cancer and adenocarcinoma. The numbers of accurate HSIL and LSIL diagnoses by conventional colposcopy for the test dataset were 43 out of 51 and for all datasets were and 202 out of 253. Compared with the classifier, the conventional colposcopy results for the test dataset and for all of the datasets were not significantly different, which suggested that the AI classifier using deep learning with convolutional neural networks using images of cervical SILs combined with HPV types was not inferior to conventional colposcopy performed by gynecologic oncologists.

In the present study, 12 cases of pathological HSIL and LSIL were HPV-negative, although both HPV type information and colposcopy images were used for analysis. These cases may have represented false negatives as HPV infection is essential to the transformation of cervical epithelial cells ([@b11-ol-0-0-11214]) and the HPV detection kits that were commercially available and widely used result in \<3.1% of false negatives in pathological HSIL in Japan as stated by the manufacturer. The data not excluded as only a small number of HPV-negative cases were identified. Previous studies have reported 8--13% of false negative results for HPV detection ([@b44-ol-0-0-11214]--[@b46-ol-0-0-11214]). Lee *et al* ([@b47-ol-0-0-11214]) reported that the classic nested PCR and Sanger DNA sequencing technology for routine HPV testing exhibited that a true negative HPV PCR invariably indicated the absence of precancerous cells in the cytology samples.

The accuracy of 0.941 was an acceptable result of the classifier for deep learning. In medicine, several studies have used AI for deep learning with convolutional neural networks ([@b48-ol-0-0-11214],[@b49-ol-0-0-11214]). The accuracy values of AI with deep learning have been published and include 0.997 for the histopathological diagnosis of breast cancer ([@b50-ol-0-0-11214]), 0.980 for the morphological quality of blastocysts and evaluation by an embryologist ([@b51-ol-0-0-11214]), 0.640--0.880 for predicting live birth from a blastocyst image of patients by age ([@b4-ol-0-0-11214],[@b52-ol-0-0-11214]), 0.650 for predicting live birth without aneuploidy from a blastocyst image ([@b53-ol-0-0-11214]), 0.823 ([@b3-ol-0-0-11214]), 0.720 ([@b54-ol-0-0-11214]) and 0.500 ([@b55-ol-0-0-11214]) for colposcopy, 0.830 to 0.900 for the early diagnosis of Alzheimer\'s disease ([@b56-ol-0-0-11214]), 0.830 for urological dysfunctions ([@b57-ol-0-0-11214]) and 0.830 for the diagnostic imaging of orthopedic trauma ([@b58-ol-0-0-11214]). A number of studies have reported a limitation of conventional colposcopy. A study of the accuracy of biopsy under colposcopy reported a total biopsy failure rate, comprising both non-biopsy and incorrect selection of biopsy site, of 0.200 in CIN1, 0.110 in CIN2 and 0.090 in CIN3 ([@b59-ol-0-0-11214]). The colposcopic impression of high-grade CIN had a specificity of 0.880 and a sensitivity of 0.540, as determined by nine expert colposcopists in 100 cervigrams ([@b60-ol-0-0-11214]). The sensitivity of an online colpophotographic assessment of HSIL by 20 colposcopists was 0.390 ([@b61-ol-0-0-11214]). Thus, conventional colposcopy does not provide good sensitivity, even when performed by colposcopy specialists. By contrast, the accuracy and sensitivity reported in this study for predicting HSIL from colposcopy images combined with HPV types using deep learning were 0.941 and 0.956, respectively, which appears to be satisfactory. Since the classifier was not trained in colposcopy findings such as mosaic acetowhite epithelium and punctuation, it may recognize certain morphological features of cervical SILs by itself. It is also possible that the AI classifier may recognize features that colposcopists do not, such as relative or absolute brightness of acetowhite, complexity of the shape of the lesion, quantitative marginal evaluation of borders and distribution of punctuation density. The pathological results in the present study were obtained and defined by punch biopsy as it was not recommended for patients with CIN1 (LSIL) diagnosed by colposcopy to undergo conization or hysterectomy. The advanced lesion would have been revealed if the pathological results were defined by conization or hysterectomy rather than by punch biopsy; thus, both conventional colposcopy and the AI classifier may have demonstrated different results. When AI is used for advanced diseases, such as squamous cell carcinoma and adenocarcinoma, the pathological diagnosis should be provided by conization or hysterectomy.

It is important for clinicians to distinguish HSIL from LSIL in biopsy specimens in clinical practice as further examination or treatment, such as conization, may be required for HSIL. The clinician should consider biopsy when a reliable classifier indicates HSIL in clinical practice. The classifier developed in the present study may help untrained gynecologists avoid or reduce the risk of misidentifying HSIL. When the performance of the AI classifier is further improved in accuracy, sensitivity and specificity for classifying SILs, gynecologists may be able to obtain more precise classification without requiring a colposcopy specialist.

Several reasons for obtaining high accuracy by AI were considered in the present study. First, the association between the pathological results, colposcopy diagnosis and HPV types was important. The pathological results were affected by the HPV types. However, no association was identified between HPV types and the results of colposcopy. Thus, HPV types and colposcopy were associated with pathological results, but not with each other. In our preliminary study, the accuracy achieved by deep learning with only images of colposcopy was 0.823 (data not shown). Thus, the association among the pathological results, colposcopy diagnosis and HPV type may be a reason for high accuracy.

Second, AI has the ability to use images and non-image data simultaneously. However, AI is not established to digitize images to numerical data indicating the features of the images for multivariate analysis; AI, including deep learning, can acquire numerical data to indicate the features of an image and use the numerical data indicating the features of colposcopy images and the numeric tensor data of HPV types. This is an important feature of AI, which may be the second reason for high accuracy in this study from the perspective of computer science.

Third, in the present study, the neural network architecture including a batch normalization layer ([@b29-ol-0-0-11214]) was adequate. Neural network architecture is a key component of deep learning. A batch normalization layer was added following catenating information from colposcopy images and HPV types. This method makes normalization a part of the model architecture and performs the normalization for each training mini-batch. Batch normalization allows the use of high learning rates. This architecture may be the third reason for high accuracy in the present study.

The architecture of the neural network has been progressing. The LeNet study in 1998 ([@b62-ol-0-0-11214]) consisted of 5 layers. AlexNet in 2012 ([@b30-ol-0-0-11214]) consisted of 14, and Google Net in 2014 ([@b26-ol-0-0-11214]) was constructed from a combination of micronetworks. ResNet-50 in 2015 ([@b63-ol-0-0-11214]) consisted of modules with a shortcut process. Squeeze-and-excitation networks were first published in 2017 ([@b64-ol-0-0-11214]). However, AI for image recognition remains in development. Image information is one of the parameters requiring further investigation. Only 15×15 pixels have been used to detect cervical cancer ([@b65-ol-0-0-11214]); thus, image size remains an issue. In a previous colposcopy study, the reported accuracy for images of 150×150 pixels was higher compared with that for images of 300×300 or 32×32 pixels ([@b55-ol-0-0-11214]). In the present study, 111×111, 70×70 and 50×50 pixel images were tested. A size of 50×50 pixels, which exhibited the best performance in the present study, falls within the acceptable range. Regularization values that are routinely used in developing AI of deep learning are also an important hyperparameter for constructing a good classifier that avoids overfitting ([@b35-ol-0-0-11214]--[@b40-ol-0-0-11214]). Selecting the appropriate number of training datasets is also very important; in addition, the validation dataset prevents overfitting. Generally, more varied patterns of images may be needed for datasets as 500--1,000 images are reportedly prepared for each class during image classification with deep learning ([@b52-ol-0-0-11214],[@b66-ol-0-0-11214]). The classifier that uses both image and HPV types may require more images combined with HPV types, which may result in improvement in the classifier with deep learning.

In the present study, a classifier was developed based on deep learning that used both HPV types and images of uterine cervical SILs to predict pathological HSIL/LSIL. The accuracy of the classifier was 0.941. Although further study using more datasets and modified neural network architecture and/or hyperparameters is required to validate the classifier, the results of the present study demonstrated that AI may have a potential for clinical use in colposcopy examinations and may provide benefits to patients and clinicians.
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![Development the AI classifier with deep learning for colposcopy images and HPV types. HPV, human papilloma virus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; AI, artificial intelligence.](ol-19-02-1602-g00){#f1-ol-0-0-11214}

###### 

Architecture of the classifier.

  Input Image                        Input HPV Type
  ---------------------------------- ----------------
    1. Convolutional layer           −
    2. Rectified linear unit layer   −
    3. Pooling layer                 −
    4. Convolutional layer           −
    5. Rectified linear unit layer   −
    6. Pooling layer                 −
    7. Flattening layer              −
    8. Linear layer                  −
    9. Rectified linear unit layer   −
  10\. Linear layer                  1\. HPV type
  Catenated layer                    
  Batch normalization layer          
  Linear layer                       
  Softmax layer                      
  Output                             

The classifier consisted of a combination of 10 layers of a convolutional neural network and a single layer of an HPV type tensor. The image processing and HPV type tensor were combined at the catenated layer. '−', no HPV type combined with the layer; HPV, human papilloma virus.

###### 

Patients with pathological results confirmed by punch biopsy and different HPV types.

                                    Pathological results                     
  --------------------------------- ---------------------- ----- --- --- --- ---
  Not available                       3                    54    0   0   0   0
  HPV-negative                        6                      6   0   0   0   1
  High risk but not type 16 or 18   123                    33    1   2   0   0
  Type 16                             75                     2   0   8   0   2
  Type 18                             5                      2   0   0   2   1
  Type 16+18                          1                      0   0   2   0   1

HPV, human papilloma virus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma.

###### 

Patients with pathological results confirmed by punch biopsy and conventional colposcopy diagnosis by gynecologic oncologists.

                             Colposcopy diagnosis                  
  -------------------------- ---------------------- ---- ----- --- ---
  HSIL                       32                     63   114   1   3
  LSIL                       70                     17   5     5   0
  Microinvasive SCC          0                      0    1     0   0
  Invasive SCC               0                      0    4     0   8
  Adenocarcinoma *in situ*   0                      0    2     0   0
  Adenocarcinoma             0                      0    1     0   4

LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma; CIN, cervical intraepithelial neoplasia.

###### 

Patients with all types of HPV and the conventional colposcopy diagnosis by gynecologic oncologists.

                                    Colposcopy diagnosis                 
  --------------------------------- ---------------------- ---- ---- --- ---
  Not available                     48                     9    0    0   0
  HPV-negative                      4                      5    1    2   1
  High risk but not type 16 or 18   40                     46   70   2   1
  Type 16                           9                      18   50   1   9
  Type 18                           1                      2    5    1   1
  Type 16 + 18                      0                      0    1    0   3

HPV, human papilloma virus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; CIN, cervical intraepithelial neoplasia.

###### 

The results of the best AI classifier combined with HPV types and conventional colposcopy for 51 test datasets (20% of all qualified datasets).

  Variable                    AI              Conventional colposcopy
  --------------------------- --------------- -------------------------
  Accuracy                    0.941 (48/51)   0.843 (43/51)
  Sensitivity                 0.956 (43/45)   0.844 (38/45)
  Specificity                 0.833 (5/6)     0.833 (5/6)
  Positive predictive value   0.977 (43/44)   0.974 (38/39)
  Negative predictive value   0.714 (5/7)     0.500 (6/12)
  Youden\'s J index           0.789           0.677
  AUC (± standard error)      0.963±0.026     N/A
  Cohen\'s κ                  0.769           0.473

AUC, area under the receiver operating characteristic curve; HPV, human papilloma virus; AI, artificial intelligence.

###### 

Comparison of the diagnosis of conventional colposcopy by gynecological oncologists and the best AI classifier and the pathological results for patients with HSIL or LSIL in the test dataset.

                    AI diagnosis (image combined with HPV type)   Pathological diagnosis        
  ----------------- --------------------------------------------- ------------------------ ---- ---
  HSIL              36                                            2                        38   0
  LSIL              6                                             4                        5    5
  Cervicitis        1                                             1                        1    1
  Invasive cancer   1                                             0                        1    0

HPV, human papilloma virus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; AI, artificial intelligence.
